Company Profiles

driven by the PitchBook Platform

Adagene

Description

Operator of an antibody discovery and engineering company designed to generate, engineer and produce human antibodies. The company's smart antibody technology increases success rates, substantially accelerates time to market and reduces the costs associated with developing a therapeutic antibody, enabling healthcare providers to provide treatment for inflammation and infectious diseases.

2011

Founded

PRIVATE

Status

Series B

Latest Deal Type

$28M

Latest Deal Amount

$36M

Total Amount Raised

5

Investors

Description

Operator of an antibody discovery and engineering company designed to generate, engineer and produce human antibodies. The company's smart antibody technology increases success rates, substantially accelerates time to market and reduces the costs associated with developing a therapeutic antibody, enabling healthcare providers to provide treatment for inflammation and infectious diseases.

Website:

www.adagene.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Healthcare Technology Systems

Primary Office

4F, Building C14 218 Xinghu Street, Suzhou Industrial Park Jiangsu, 215123China +85 (0)12 8777 3632
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Adagene's full profile, request a free trial.

    Adagene Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Adagene Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Eight Roads VenturesVenture CapitalMinority000 0000000 0000
    F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
    GP Healthcare CapitalVenture CapitalMinority000 0000000 0000
    New World TMTCorporationMinority000 0000000 0000
    WuXi Healthcare Investment Consulting (Shanghai)Corporate Venture CapitalMinority000 0000000 0000
    Eight Roads Ventures Venture Capital
    F-Prime Capital Partners Venture Capital
    GP Healthcare Capital Venture Capital
    New World TMT Corporation
    WuXi Healthcare Investment Consulting (Shanghai) Corporate Venture Capital

    Adagene Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Peter Luo Ph.DChief Executive Officer, Co-Founder and Board Member
    Max DawsonVice President, Business Development
    Yan LiVice President of Bioinformatics and IT
    Kristine SheVice President of Operations
    Felix Du Ph.DVice President of Technology Development
    Peter Luo Ph.D Chief Executive Officer, Co-Founder and Board Member
    Max Dawson Vice President, Business Development
    Yan Li Vice President of Bioinformatics and IT
    Kristine She Vice President of Operations
    Felix Du Ph.D Vice President of Technology Development

    Adagene Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Daniel AuerbachBoard Member000 0000
    Ge Li Ph.DWuXi AppTecCo-Founder, Chairman and Chief Executive Officer000 0000
    Peter Luo Ph.DAdageneChief Executive Officer, Co-Founder and Board Member000 0000
    Thomas Beck MDBoard Member000 0000
    Xiaoyan Wang Ph.DSelfBoard Member000 0000
    Daniel Auerbach Board Member
    Ge Li Ph.D Co-Founder, Chairman and Chief Executive Officer WuXi AppTec
    Peter Luo Ph.D Chief Executive Officer, Co-Founder and Board Member Adagene
    Thomas Beck MD Board Member
    Xiaoyan Wang Ph.D Board Member Self
    Request full access to PitchBook